90Y-DOTA-hLL2

Yttrium-90 labeled DOTA-hLL2 · French Innovative Leukemia Organisation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 90Y-DOTA-hLL2, covering 2018-04-27 to 2018-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma [Phase 2]

See pricing